吉林医学
吉林醫學
길림의학
JILIN MEDICAL JOURANL
2015年
12期
2482-2483,2484
,共3页
陈洁华%肖文娟%邹燕芳%李晓春%熊斌%吴建能
陳潔華%肖文娟%鄒燕芳%李曉春%熊斌%吳建能
진길화%초문연%추연방%리효춘%웅빈%오건능
糖尿病周围神经病%硫辛酸%视诱发电位%神经传导速度%视神经病变
糖尿病週圍神經病%硫辛痠%視誘髮電位%神經傳導速度%視神經病變
당뇨병주위신경병%류신산%시유발전위%신경전도속도%시신경병변
Diabetic Peripheral Neuropathy%Alpha Lipoic Acid(α-LA)%Visual Evoked Potential%Nerve Conduction Velocity%Optic Neuropathy
目的:观察α-硫辛酸治疗2型糖尿病合并周围神经病变( DPN)对视诱发电位影响。方法:将80例糖尿病性周围神经病变患者随机分为两组,各40例。对照组给予甲钴胺500μg静脉推注,1次/d;治疗组α-硫辛酸600 mg稀释后静脉滴注,1次/d,用药2周。选定视诱发电位P100波幅作为视力量化评价指标,两组治疗前后P100进行对照研究分析。结果:治疗前治疗组视诱发电位P100波振幅及潜伏期分别为(0.198±0.031)μV(、100.197±7.354)ms,对照组视诱发电位P100波振幅及潜伏期分别为(0.198±0.035)μV(、100.191±7.665)ms,两者比较差异均无统计学意义(P>0.05)。治疗后对照组P100波振幅及潜伏期分别为(0.209±0.016)μV(、100.104±9.003)ms,治疗组P100波振幅及潜伏期分别为(0.236±0.015)μV、(97.668±6.783)ms,与治疗前相比,差异均有统计学意义(P<0.05);与对照相比差异均有统计学意义(P<0.05)。结论:α-硫辛酸早期应用对糖尿病视网膜病变单纯期视诱发电位P100波潜时及振幅有影响,提示对视力、视神经传导有保护作用。
目的:觀察α-硫辛痠治療2型糖尿病閤併週圍神經病變( DPN)對視誘髮電位影響。方法:將80例糖尿病性週圍神經病變患者隨機分為兩組,各40例。對照組給予甲鈷胺500μg靜脈推註,1次/d;治療組α-硫辛痠600 mg稀釋後靜脈滴註,1次/d,用藥2週。選定視誘髮電位P100波幅作為視力量化評價指標,兩組治療前後P100進行對照研究分析。結果:治療前治療組視誘髮電位P100波振幅及潛伏期分彆為(0.198±0.031)μV(、100.197±7.354)ms,對照組視誘髮電位P100波振幅及潛伏期分彆為(0.198±0.035)μV(、100.191±7.665)ms,兩者比較差異均無統計學意義(P>0.05)。治療後對照組P100波振幅及潛伏期分彆為(0.209±0.016)μV(、100.104±9.003)ms,治療組P100波振幅及潛伏期分彆為(0.236±0.015)μV、(97.668±6.783)ms,與治療前相比,差異均有統計學意義(P<0.05);與對照相比差異均有統計學意義(P<0.05)。結論:α-硫辛痠早期應用對糖尿病視網膜病變單純期視誘髮電位P100波潛時及振幅有影響,提示對視力、視神經傳導有保護作用。
목적:관찰α-류신산치료2형당뇨병합병주위신경병변( DPN)대시유발전위영향。방법:장80례당뇨병성주위신경병변환자수궤분위량조,각40례。대조조급여갑고알500μg정맥추주,1차/d;치료조α-류신산600 mg희석후정맥적주,1차/d,용약2주。선정시유발전위P100파폭작위시역량화평개지표,량조치료전후P100진행대조연구분석。결과:치료전치료조시유발전위P100파진폭급잠복기분별위(0.198±0.031)μV(、100.197±7.354)ms,대조조시유발전위P100파진폭급잠복기분별위(0.198±0.035)μV(、100.191±7.665)ms,량자비교차이균무통계학의의(P>0.05)。치료후대조조P100파진폭급잠복기분별위(0.209±0.016)μV(、100.104±9.003)ms,치료조P100파진폭급잠복기분별위(0.236±0.015)μV、(97.668±6.783)ms,여치료전상비,차이균유통계학의의(P<0.05);여대조상비차이균유통계학의의(P<0.05)。결론:α-류신산조기응용대당뇨병시망막병변단순기시유발전위P100파잠시급진폭유영향,제시대시력、시신경전도유보호작용。
objective To study the effect on visual evoked potential of alpha lipoic acid in the treatment of type 2 diabetic peripheral neu-ropathy. Method 80 patients of diabetic peripheral neuropathy were randomly divided into control group and trial group (n=40). The control group was treated with methylcobalamin 500μg intravenous injection,once every day. The trial group was treated with alpha lipoic acid 600 mg intravenous drip after dilution,once every day. The course of treatment was 2 weeks. The P100 amplitude of visual evoked potential was select-ed as the quantitative evaluation indicator of vision. The P100 before and after treatment in two groups were compared for statistical analy-sis. Results Before treatment,in control group the P100 amplitude and latentperiod of visual evoked potential were(0. 198 ± 0. 035)μV、(100. 191 ± 7. 665)ms respectively,in trial group the P100 amplitude and latentperiod of visual evoked potential were(0. 198 ± 0. 031)μV、(100. 197 ± 7. 354)ms respectively. There were no statistical significance(P>0. 05). After treatment,in trial group the P100 amplitude and latentperiod of visual evoked potential were(0. 236 ± 0. 015)μV(、97. 668 ± 6. 783)ms respectively,in control group the P100 amplitude and latentperiod of visual evoked potential were(0. 209 ± 0. 016)μV(、100. 104 ± 9. 003)ms respectively. There were statistical significance be-tween before treatment and after treatment(P<0. 05). There were statistical significance between control group and trial group(P<0. 05) . Conclusion The is a certain influence of alpha lipoic acid in the early treatment of simple diabetic retinopathy on the P100 amplitude and la-tentperiod of visual evoked potential. This indicates that alpha lipoic acid has a protective effect on the eyesight and optic nerve conduction.